Genomic aberrations in plasma cell leukemia shown by interphase fluorescence in situ hybridization

被引:34
作者
Chang, H
Sloan, S
Li, D
Patterson, B
机构
[1] Univ Toronto, Princess Margaret Hosp, Univ Hlth Network, Dept Lab Hematol,Dept Lab Med & Pathobiol, Toronto, ON M5G 2M9, Canada
[2] Univ Toronto, Princess Margaret Hosp, Univ Hlth Network, Div Med Oncol & Hematol, Toronto, ON M5G 2M9, Canada
关键词
D O I
10.1016/j.cancergencyto.2004.05.004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A combination of cytoplasmic immunofluorescence to detect the immunoglobulin light chain and an interphase fluorescence in situ hybridization technique was used to study the recurrent genetic abnormalities in 14 patients with plasma cell leukemia (PCL). Of the 14 patients studied, 5 had primary and 9 secondary PCL. Chromosomal abnormalities were detected in all 14 patients (100%). Deletions of 13q14 were detected in 11 (78%) cases and deletions of 17p13.1 (TP53) in 6 (43%) cases. Translocations (11;14), (4;14), and (14;16) were found in 5 (35%), 2 (14%), and 1 (7%) cases, respectively. Except for an association between t(4;14) and 13q14 deletions, no association was identified among the genetic abnormalities. Our study revealed that recurrent genetic changes are more frequent in PCL than in multiple myeloma. The frequent TP53 deletions may represent a marker of genetic instability giving rise to an increased propensity for myeloma cells to emigrate from the bone marrow environment and enter leukemic phase. (C) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:150 / 153
页数:4
相关论文
共 25 条
  • [1] A novel three-color, clone-specific fluorescence in situ hybridization procedure for monoclonal gammopathies
    Ahmann, GJ
    Jalal, SM
    Juneau, AL
    Christensen, ER
    Hanson, CA
    Dewald, GW
    Greipp, PR
    [J]. CANCER GENETICS AND CYTOGENETICS, 1998, 101 (01) : 7 - 11
  • [2] Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentation
    Avet-Loiseau, H
    Facon, T
    Grosbois, B
    Magrangeas, F
    Rapp, MJ
    Harousseau, JL
    Minvielle, S
    Bataille, R
    [J]. BLOOD, 2002, 99 (06) : 2185 - 2191
  • [3] Avet-Loiseau H, 1999, GENE CHROMOSOME CANC, V24, P9, DOI 10.1002/(SICI)1098-2264(199901)24:1<9::AID-GCC2>3.0.CO
  • [4] 2-K
  • [5] Cytogenetic, interphase, and multicolor fluorescence in situ hybridization analyses in primary plasma cell leukemia:: a study of 40 patients at diagnosis, on behalf of the Intergroupe Francophone du Myelome and the Groupe Francais de Cytogenetique Hematologique
    Avet-Loiseau, H
    Daviet, A
    Brigaudeau, C
    Callet-Bauchu, E
    Terré, C
    Lafage-Pochitaloff, M
    Désangles, F
    Ramond, S
    Talmant, P
    Bataille, R
    [J]. BLOOD, 2001, 97 (03) : 822 - 825
  • [6] Chromosome translocations in multiple myeloma
    Bergsagel, PL
    Kuehl, WM
    [J]. ONCOGENE, 2001, 20 (40) : 5611 - 5622
  • [7] CARCIASANZ R, 1999, BLOOD, V93, P1032
  • [8] CANCER PROGRESSION AND P53
    CARSON, DA
    LOIS, A
    [J]. LANCET, 1995, 346 (8981): : 1009 - 1011
  • [9] Frequent monoallelic loss of D13S319 in multiple myeloma patients shown by interphase fluorescence in situ hybridization
    Chang, H
    Bouman, D
    Boerkoel, CF
    Stewart, AK
    Squire, JA
    [J]. LEUKEMIA, 1999, 13 (01) : 105 - 109
  • [10] The t(4;14) is associated with poor prognosis in myeloma patients undergoing autologous stem cell transplant
    Chang, H
    Sloan, S
    Li, D
    Zhuang, LH
    Yi, QL
    Chen, CI
    Reece, D
    Chun, K
    Stewart, AK
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2004, 125 (01) : 64 - 68